Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Fish Oil
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Glogen Clinical Research Pvt. Ltd
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
January 06, 2025
Lead Product(s) : Fish Oil
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Glogen Clinical Research Pvt. Ltd
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Fish Oil
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Omega-3 Supplement and Health Markers
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
July 09, 2024
Lead Product(s) : Fish Oil
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Fish Oil
Therapeutic Area : Undisclosed
Study Phase : Phase II
Sponsor : University Hospital, Bonn | University Hospital Muenster | University Hospital Göttingen | University Hospital Schleswig-Holstein | Charite University, Berlin, Germany | Wuerzburg University Hospital | Johannes Gutenberg University Mainz | University Hosp
Deal Size : Inapplicable
Deal Type : Inapplicable
Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
February 28, 2024
Lead Product(s) : Fish Oil
Therapeutic Area : Undisclosed
Highest Development Status : Phase II
Sponsor : University Hospital, Bonn | University Hospital Muenster | University Hospital Göttingen | University Hospital Schleswig-Holstein | Charite University, Berlin, Germany | Wuerzburg University Hospital | Johannes Gutenberg University Mainz | University Hosp
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Fish Oil
Therapeutic Area : Psychiatry/Psychology
Study Phase : Phase II/ Phase III
Sponsor : Sunnybrook Health Sciences Centre | Lotte & John Hecht Memorial Foundation
Deal Size : Inapplicable
Deal Type : Inapplicable
Perinatal Depression & Anxiety (PDA) and Maternal Gut Microbiome
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
October 10, 2023
Lead Product(s) : Fish Oil
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase II/ Phase III
Sponsor : Sunnybrook Health Sciences Centre | Lotte & John Hecht Memorial Foundation
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Fish Oil
Therapeutic Area : Neurology
Study Phase : Undisclosed
Sponsor : True Eye Experts - New Tampa
Deal Size : Inapplicable
Deal Type : Inapplicable
The Effects of VisionPureâ„¢ on Indices of Vision Health and Cognitive Function
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
September 09, 2022
Lead Product(s) : Fish Oil
Therapeutic Area : Neurology
Highest Development Status : Undisclosed
Sponsor : True Eye Experts - New Tampa
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Fish Oil
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Effects of Nutritional Intervention With Fish-derived Lipids in Improving Antiviral Immunity
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
August 16, 2022
Lead Product(s) : Fish Oil
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Fish Oil
Therapeutic Area : Oncology
Study Phase : Undisclosed
Sponsor : Institutos Madrileño de Estudios Avanzados | Oncoclínicas
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
July 16, 2021
Lead Product(s) : Fish Oil
Therapeutic Area : Oncology
Highest Development Status : Undisclosed
Sponsor : Institutos Madrileño de Estudios Avanzados | Oncoclínicas
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Fish Oil
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Undisclosed
Sponsor : Danone Nutricia Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Impact of Fish Oil Dose on Tissue Content and Function
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
February 26, 2021
Lead Product(s) : Fish Oil
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Undisclosed
Sponsor : Danone Nutricia Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Fish Oil
Therapeutic Area : Psychiatry/Psychology
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
April 02, 2019
Lead Product(s) : Fish Oil
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Fish Oil
Therapeutic Area : Psychiatry/Psychology
Study Phase : Phase I
Sponsor : VA Connecticut Healthcare System
Deal Size : Inapplicable
Deal Type : Inapplicable
Fish Oil vs. Placebo on Subjective Effects of Alcohol
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
January 05, 2017
Lead Product(s) : Fish Oil
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase I
Sponsor : VA Connecticut Healthcare System
Deal Size : Inapplicable
Deal Type : Inapplicable